ArticleAlzheimer's research & therapy2026
Outer nuclear layer thinning as an in vivo biomarker for discriminating probable FTLD-tau from probable FTLD-TDP with PET-supported subtyping.
Zhengxi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.